Status:
TERMINATED
A Couples-based Intervention for Transgender Women and Their Partners
Lead Sponsor:
University of Michigan
Collaborating Sponsors:
University of California, San Francisco
Emory University
Conditions:
HIV Infections
HIV Primary Infection
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This project seeks to test the efficacy of a couples-based HIV prevention program in large-scale randomized controlled trial (RCT) to reduce HIV risk among transgender woman and their partners. This p...
Detailed Description
Transgender women (trans women; individuals with a feminine and/or female gender identity who were assigned male at birth) are disproportionately affected by HIV. One of the most consistently reported...
Eligibility Criteria
Inclusion
- Age 18 or older
- Self-report that they are in emotional and/or sexual relationship for at least three months
- One partner must identify as a trans women (assigned the male gender at birth but identify as female or as a trans woman)
- Both partners must have engaged in condomless sex within the past 6 months with any partner
- Able to provide informed consent
- Speak and read English
Exclusion
- Currently psychotic, suicidal, or manic
- Either partner reports that participating in the study would cause them physical harm
Key Trial Info
Start Date :
November 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2024
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT04067661
Start Date
November 1 2019
End Date
April 30 2024
Last Update
August 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco
San Francisco, California, United States, 94158